Weiss Asset discloses 11.1M Avadel stake on Form 3
Avadel Pharmaceuticals received a Form 3 indicating that Weiss Asset Management LP and Andrew Weiss are reporting as ten percent owners.
Rhea-AI Filing Summary
Avadel Pharmaceuticals received a Form 3 indicating that Weiss Asset Management LP and Andrew Weiss are reporting as ten percent owners. The filing shows indirect beneficial ownership of 11,112,052 ordinary shares, held by two private investment funds managed by Weiss Asset Management. The reporting parties and related entities disclaim beneficial ownership except for their pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Weiss Asset Management LP, WEISS ANDREW M
Role
10% Owner | 10% Owner
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Ordinary Shares — 11,112,052 shares (Indirect, See Footnote 1)
Footnotes (1)
- F1. Shares reported herein represent shares beneficially owned by two private investment funds for which Weiss Asset Management LP serves as investment manager. WAM GP LLC is the general partner of Weiss Asset Management LP and Andrew Weiss is the Manager of WAM GP LLC. All of Weiss Asset Management LP, WAM GP LLC, and Andrew Weiss disclaim beneficial ownership of the shares reported herein except to the extent of their pecuniary interest therein.
FAQ
What does the Weiss Asset Management Form 3 for AVDL disclose?
The Form 3 discloses that Weiss Asset Management LP and Andrew Weiss are ten percent owners of Avadel Pharmaceuticals, reporting indirect beneficial ownership of 11,112,052 ordinary shares held through two private investment funds managed by Weiss Asset Management LP.
Is the Avadel (AVDL) Form 3 a buy or sell transaction?
This Form 3 does not report a buy or sell transaction. It is an initial ownership statement showing existing indirect beneficial ownership of 11,112,052 Avadel ordinary shares, rather than a new purchase or sale in the market.
AI-generated analysis. How Rhea-AI works. Not financial advice.